文献速递妇科

腹横肌平面阻滞时机对微创子宫切除术患者阿片类药物用量(吗啡毫克当量)及术后即刻疼痛评分的影响:回顾性队列研究

The Effect of Transversus Abdominis Plane Block Timing on Milliequivalents of Opioid Use and Immediate Postoperative Pain Scores in Patients Undergoing Minimally Invasive Hysterectomy: A Retrospective Cohort Study.
PubMed 文献 · J Minim Invasive Gynecol · 2023-12-25

该回顾性单机构队列研究纳入2982例2018年1月至2022年12月因良性指征行微创全子宫切除术的患者,比较无TAP阻滞、术前TAP阻滞与术后TAP阻滞三组的术后阿片类药物用量(MME)和疼痛评分。结果显示TAP阻滞组平均阿片用量显著低于无阻滞组(MME 43.2 vs 53.9,p=.002),但术前与术后阻滞组间无显著差异(MME 43.4 vs 42.1,p=.752)。术前阻滞较术后阻滞显著缩短出院时间(中位5.3 vs 6.2小时,p=.001)。

要点

  • TAP阻滞组平均阿片用量显著低于无阻滞组(MME 43.2 vs 53.9,p=.002)。
  • 术前与术后TAP阻滞组间平均阿片用量无显著差异(MME 43.4 vs 42.1,p=.752)。
  • 术前TAP阻滞较术后阻滞显著缩短出院时间(中位5.3 vs 6.2小时,p=.001)。

核心结论

  • 微创子宫切除术时使用TAP阻滞可减少术后阿片类药物用量,但术前或术后阻滞时机对阿片用量无显著影响。
  • 术前较术后行TAP阻滞显著缩短出院时间。

研究设计与样本

  • 回顾性单机构队列研究,纳入2018年1月至2022年12月因良性指征行微创全子宫切除术的2982例患者。
  • 排除恶性肿瘤诊断、同期泌尿妇科手术、阴道子宫切除术、宫颈上子宫切除术或术前3个月内有阿片类药物使用史的患者。
  • 分为无TAP阻滞组(n=1966,65.9%)、术前TAP阻滞组(854例,28.6%)和术后TAP阻滞组(162例,5.4%)。
  • 采用汇总统计和混合效应回归方法进行数据分析。

主要发现

  • 接受TAP阻滞(术前或术后)的患者平均阿片用量显著低于未接受阻滞者(MME 43.2 vs 53.9,p=.002)。
  • 术前与术后TAP阻滞组间平均阿片用量无显著差异(MME 43.4 vs 42.1,p=.752)。
  • 有无TAP阻滞组间术后疼痛评分无差异,但无阻滞组需更多阿片类药物才能达到与阻滞组相同的疼痛评分。
  • TAP阻滞组较无阻滞组出院时间显著缩短(中位5.5 vs 6.3小时,p≤.001)。
  • 术前TAP阻滞组较术后TAP阻滞组出院时间显著缩短(中位5.3 vs 6.2小时,p=.001)。

临床怎么用

  • 微创子宫切除术时可考虑使用TAP阻滞以减少术后阿片类药物用量。
  • 若选择TAP阻滞,术前给药可能缩短出院时间。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To examine the effect of transversus abdominis plane (TAP) block timing (preoperative or postoperative) on postoperative opioid use (quantified via morphine milligram equivalents; MME) and pain scores in patients undergoing minimally invasive hysterectomy for benign indications. DESIGN: Retrospective, single-institution cohort study SETTING: Academic-affiliated community hospital PATIENTS: A total of 2982 patients were included who underwent a minimally invasive total hysterectomy between January 2018 and December 2022, excluding patients with a malignancy diagnosis, concurrent urogynecological procedure, vaginal hysterectomy, supracervical hysterectomy, or those with baseline narcotic use (opioid use within the 3 months before surgery). Patients were separated into 3 groups: no TAP blocks (n = 1966, 65.9%), preoperative TAP blocks (854, 28.6%), and postoperative TAP blocks (162, 5.4%). INTERVENTIONS: Summary statistics and mixed-effects regression methods were used for data analysis. MEASUREMENTS AND MAIN RESULTS: There was a statistically significant lower mean use of opioids (MME 43.2 vs 53.9, p = .002) among patients who received a TAP block (either pre or postoperatively) than those who did not receive a block. However, when comparing preoperative vs postoperative patients with TAP block, there was no statistically significant difference in mean opioid use (MME 43.4 vs 42.1, p = .752). There were no differences in postoperative pain scores between patients with and without a TAP block, however, more opioids were required in patients who did not receive a TAP block to achieve the same pain scores as those who did receive a TAP block. There was a statistically significant shorter time to discharge for TAP versus patients without TAP block(median 5.5 vs 6.3 hours, p ≤ .001) as well as preoperative versus postoperative patients with TAP block (median 5.3 vs 6.2 hours, p = .001). CONCLUSION: While TAP block use at the time of minimally invasive hysterectomy reduced use of postoperative opioids, the timing of TAP block, either preoperatively or postoperatively, did not significantly affect opioid use. Preoperative compared with postoperative TAP block administration significantly shortened the time to discharge.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Chang-Patel EJ, Wong JMK, Gould CH, et al. The Effect of Transversus Abdominis Plane Block Timing on Milliequivalents of Opioid Use and Immediate Postoperative Pain Scores in Patients Undergoing Minimally Invasive Hysterectomy: A Retrospective Cohort Study. J Minim Invasive Gynecol. 2023. PMID: 38151093. doi:10.1016/j.jmig.2023.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。